Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Cassava Sciences shares drop in pre-open trade after $40 mln SEC settlement

Published 09/27/2024, 08:38 AM
© Reuters
SAVA
-

Investing.com -- Shares of Cassava Sciences, Inc (NASDAQ:SAVA) dropped 11.5% in pre-open trade on Friday following the company's statement that it has reached a $40 million settlement with the U.S. Securities and Exchange Commission (SEC) over negligence-based disclosure charges. 

The charges stem from an SEC investigation into statements made by the company regarding the results of its 2020 Phase 2b clinical trial of simufilam, an experimental treatment for Alzheimer’s disease.

Cassava Sciences, Inc. settled the charges with the SEC, agreeing to pay a $40 million penalty, without admitting or denying the SEC’s allegations.

Cassava stated that it fully cooperated with the SEC and has since implemented remedial measures. The $40 million penalty will impact the company's financials for the second half of 2024.

Cassava also addressed a separate investigation by the U.S. Department of Justice (DOJ), stating that it does not expect criminal charges or a resolution to be brought by the DOJ’s Criminal Division.

In July, the company announced several changes to its leadership and corporate governance, including the appointment of Richard Barry as executive chairman of the Board and his transition to chief executive on September 6. 

“We can now focus all of our attention on completion of the ongoing Phase 3 trials of simufilam,” Barry said in a statement. 

Cassava reiterated its financial outlook, projecting cash reserves of $117 to $127 million at the end of 2024, though its cash use for the latter half of the year is expected to be between $80 and $90 million, including the SEC fine.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.